ClinicalThought
View More
Expert commentary with practical insights on the recent FDA approval and use of acalabrutinib in CLL from Clinical Care Options (CCO)
Nicole Lamanna, MD
Released: January 10, 2020
This archived CE-certified Clinical Care Options webcast presents optimal nursing strategies for the management of patients with multiple myeloma.
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN
A summary slideset with a European perspective on highlights of key data in chronic lymphocytic leukemia and lymphomas from ASH 2019.
A summary slideset with a European perspective on highlights of key data in acute and chronic leukemias from ASH 2019.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.